Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection

SS Lieberman-Blum, HB Fung, JC Bandres - Clinical therapeutics, 2008 - Elsevier
Background: The emergence of viral resistance is one of the greatest challenges in the
treatment of HIV infection. Maraviroc is the first member of a new class of antiretroviral …

Role of immunoglobulin M and A antibodies in the neutralization of severe acute respiratory syndrome coronavirus 2

…, I Baine, S Arinsburg, JC Bandres… - The Journal of …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected
millions of people globally. Virus infection requires the receptor-binding domain (RBD) of the …

Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera

…, F Amanat, J Klingler, I Baine, S Arinsburg, JC Bandres… - MBio, 2021 - Am Soc Microbiol
The global coronavirus disease 2019 (COVID-19) pandemic has mobilized efforts to develop
vaccines and antibody-based therapeutics, including convalescent-phase plasma therapy, …

Extraparenchymal neurocysticercosis: report of five cases and review of management

JC Bandres, AC White Jr, T Samo… - Clinical infectious …, 1992 - academic.oup.com
Neurocysticercosis due to parenchymal cysts carries a good prognosis regardless of therapy.
Extraparenchymal neurocysticercosis (including ventricular, spinal, and subarachnoid …

Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV …

JC Bandres, QF Wang, J O'Leary, F Baleaux… - Journal of …, 1998 - Am Soc Microbiol
Chemokine receptor CXCR4 (also known as LESTR and fusin) has been shown to function
as a coreceptor for T-cell-tropic strains of human immunodeficiency virus type 1 (HIV-1). We …

[HTML][HTML] Detection of antibody responses against SARS-CoV-2 in plasma and saliva from vaccinated and infected individuals

…, GS Lambert, V Itri, S Liu, JC Bandres… - Frontiers in …, 2021 - frontiersin.org
Antibodies (Abs) are essential for the host immune response against SARS-CoV-2, and all
the vaccines developed so far have been designed to induce Abs targeting the SARS-CoV-2 …

[PDF][PDF] Cutaneous protothecosis in a patient with AIDS and a severe functional neutrophil defect: successful therapy with amphotericin B

WP Carey, Y Kaykova, JC Bandres… - Clinical infectious …, 1997 - researchgate.net
Prototheca species are achlorophyllic algae that remain rare theca, which was identified by
culture as P. wickerhamii (API 20C pathogens. Fewer than 100 cases of protothecosis have …

Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation

JC Bandres, L Ratner - Journal of Virology, 1994 - Am Soc Microbiol
Human immunodeficiency virus type 1 (HIV-1) negative factor (Nef) has been shown to
down-regulate the transcription factors NF-kappa B and AP-1 in vitro. To define the mechanism of …

Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection

JC Martín, JC Bandrés - JAIDS Journal of Acquired Immune …, 1999 - journals.lww.com
It is thought that monocyte-macrophages and probably dendritic cells play a central role in
HIV-1 primary infection, as well as in its evolution, given that they are among the first cells …

Heat susceptibility of bacterial enteropathogens: implications for the prevention of travelers' diarrhea

JC Bandres, JJ Mathewson… - Archives of internal …, 1988 - jamanetwork.com
• The heat susceptibility of four bacterial enteropathogens in foods and water was studied to
develop effective recommendations for travelers to regions where diarrheal diseases are …